Effects of shrimp oil on cardio-metabolic risk factors in children and adolescents
Abstract
Abstract:Background: Antioxidants have beneficial effects on health. Shrimp oil has Astaxanthin and omega 3 that act as powerful antioxidants and might have anti-inflammatory effects on cardiovascular diseases. This study aims to investigate the effects of shrimp oil supplementation on cardio-metabolic risk factors in overweight and obese children and adolescents. Methods: This randomized, triple-blind, placebo-controlled clinical trial was conducted on 64 overweight and obese participants with 10–18 years of age. They were randomly assigned to receive either 500 mg shrimp oil or identical placebo that contained medium-chain triglycerides once per day for eight weeks. Dietary intake was obtained using food record questionnaire for three days at baseline and at the end of the study. Fasting blood samples were obtained at baseline and after eight weeks of intervention. Results: Overall, 53 participants completed the study; 30 subjects received shrimp oil and 23 subjects received placebo. There were no significant effects of shrimp oil on total cholesterol, triglyceride, HDL-C, LDL-C and blood pressure compared with the placebo group (p>0.05). Shrimp oil had no significant effects on body mass index, waist circumference and hip circumference compared with the placebo group (p>0.05). Conclusions: Supplementation with shrimp oil had no significant effects on improving the anthropometric measures and cardio-metabolic risk factors. Future clinical trials are needed to investigate the beneficial effects of higher doses of shrimp oil on cardio-metabolic risk factors in the pediatric age groups.
References
1 Astaxanthin ameliorates features of metabolic syndrome in SHR/NDmcr-cp. Life Sci. 2007;80(6):522–9.
2 . Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel. Curr Med Res Opin. 2005;21(5):665–82.
3 . The study of anti-metabolic syndrome effect of puerarin in vitro. Life Sci. 2005;77(25):3183–96.
4 . Characteristics and storage stability of nanoliposomes loaded with shrimp oil as affected by ultrasonication and microfluidization. Food Chem. 2020;310:125916.
5 Astaxanthin vs placebo on arterial stiffness, oxidative stress and inflammation in renal transplant patients [Xanthin]: a randomised controlled trial. BMC Nephrol. 2008;9(1):17.
6 Shrimp waste extract and astaxanthin: rat alveolar macrophage, oxidative stress and inflammation. J Food Sci. 2012;77(7):H141–6.
7 . Commercial potential for Haematococcus microalgae as a natural source of astaxanthin. Trends Biotechnol. 2000;18(4):160–7.
8 . Effects of astaxanthin in obese mice fed a high-fat diet. Biosci Biotechnol Biochem. 2007;71(4):893–9.
9 Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Atherosclerosis. 2010;209(2):520–3.
10 . Positive effects of astaxanthin on lipid profiles and oxidative stress in overweight subjects. Plant Foods Hum Nutr. 2011;66(4):363–9.
11 Astaxanthin lowers plasma TAG concentrations and increases hepatic antioxidant gene expression in diet-induced obesity mice. Br J Nutr. 2014;112(11):1797–804.
12 . Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing IkB kinase-dependent NF-kB activation. Mol Cells. 2003;16:97–105.
13 Rofecoxib increases susceptibility of human LDL and membrane lipids to oxidative damage: a mechanism of cardiotoxicity. J Cardiovasc Pharmacol. 2006;47:S7–S14.
14 . Effects of astaxanthin supplementation on oxidative stress: a systematic review and meta-analysis of randomized controlled trials. Int J Vitam Nutr Res. 2020;90(1–2):179–94.
15 Preventive and therapeutic effects of astaxanthin on depressive-like behaviors in high-fat diet and streptozotocin-treated rats. Front Pharmacol. 2020;10:1621.
16 . Effects of astaxanthin supplementation in healthy and obese dogs. Vet Med (Auckl). 2019;10:29–35.
17 . Combined effect of astaxanthin and squalene on oxidative stress in vivo. Mol Cell Biochem. 2016;417(1–2):57–65.
18 . Astaxanthin improves glucose metabolism and reduces blood pressure in patients with type 2 diabetes mellitus. Asia Pac J Clin Nutr. 2018;27(2):341–6.
19 . Omega-3 polyunsaturated fatty acids and their health benefits. Annu Rev Food Sci Technol. 2018;9:345–81.
20 . Omega-3 polyunsaturated fatty acids and non-communicable diseases: meta-analysis based systematic review. Asia Pac J Clin Nutr. 2015;24(1):10–5.
21 . Omega-3 fatty acids EPA and DHA: health benefits throughout life. Adv Nutr. 2012;3(1):1–7.
22 . Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85(9):660–7.
23 International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.
24 . Shrimps – a nutritional perspective. Curr Sci. 2013:1487–91.
25 . Effects of shrimp consumption on plasma lipoproteins. Am J Clin Nutr. 1996;64(5):712–7.
26 . Astaxanthin plus berberine: a nutraceutical strategy for replicating the benefits of a metformin/fibrate regimen in metabolic syndrome. Open Heart. 2019;6(2):e000977.
27 . Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction. Cardiovasc Diabetol. 2012;11(1):125.
28 . PPAR agonists and metabolic syndrome: an established role? Int J Mol Sci. 2018;19(4):1197.
29 . Novel action of carotenoids on non-alcoholic fatty liver disease: macrophage polarization and liver homeostasis. Nutrients. 2016;8(7):391.
30 . Astaxanthin protects β-cells against glucose toxicity in diabetic db/db mice. Redox Rep. 2002;7(5):290–3.
31 Impact of divergent effects of astaxanthin on insulin signaling in L6 cells. Endocrinology. 2013;154(8):2600–12.
32 Astaxanthin functions differently as a selective peroxisome proliferator-activated receptor γ modulator in adipocytes and macrophages. Biochem Pharmacol. 2012;84(5):692–700.
33 Astaxanthin: A potential mitochondrial-targeted antioxidant treatment in diseases and with aging. Oxid Med Cell Longev. 2019;2019:3849692.
